Cargando…

Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization

HIV integrase (IN) inserts viral DNA into the host genome and is the target of the strand transfer inhibitors (STIs), a class of small molecules currently in clinical use. Another potent class of antivirals is the allosteric inhibitors of integrase, or ALLINIs. ALLINIs promote IN aggregation by stab...

Descripción completa

Detalles Bibliográficos
Autores principales: Eilers, Grant, Gupta, Kushol, Allen, Audrey, Montermoso, Saira, Murali, Hemma, Sharp, Robert, Hwang, Young, Bushman, Frederic D., Van Duyne, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016701/
https://www.ncbi.nlm.nih.gov/pubmed/36867659
http://dx.doi.org/10.1371/journal.ppat.1011097
_version_ 1784907459114041344
author Eilers, Grant
Gupta, Kushol
Allen, Audrey
Montermoso, Saira
Murali, Hemma
Sharp, Robert
Hwang, Young
Bushman, Frederic D.
Van Duyne, Gregory
author_facet Eilers, Grant
Gupta, Kushol
Allen, Audrey
Montermoso, Saira
Murali, Hemma
Sharp, Robert
Hwang, Young
Bushman, Frederic D.
Van Duyne, Gregory
author_sort Eilers, Grant
collection PubMed
description HIV integrase (IN) inserts viral DNA into the host genome and is the target of the strand transfer inhibitors (STIs), a class of small molecules currently in clinical use. Another potent class of antivirals is the allosteric inhibitors of integrase, or ALLINIs. ALLINIs promote IN aggregation by stabilizing an interaction between the catalytic core domain (CCD) and carboxy-terminal domain (CTD) that undermines viral particle formation in late replication. Ongoing challenges with inhibitor potency, toxicity, and viral resistance motivate research to understand their mechanism. Here, we report a 2.93 Å X-ray crystal structure of the minimal ternary complex between CCD(,) CTD(,) and the ALLINI BI-224436. This structure reveals an asymmetric ternary complex with a prominent network of π-mediated interactions that suggest specific avenues for future ALLINI development and optimization.
format Online
Article
Text
id pubmed-10016701
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100167012023-03-16 Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization Eilers, Grant Gupta, Kushol Allen, Audrey Montermoso, Saira Murali, Hemma Sharp, Robert Hwang, Young Bushman, Frederic D. Van Duyne, Gregory PLoS Pathog Research Article HIV integrase (IN) inserts viral DNA into the host genome and is the target of the strand transfer inhibitors (STIs), a class of small molecules currently in clinical use. Another potent class of antivirals is the allosteric inhibitors of integrase, or ALLINIs. ALLINIs promote IN aggregation by stabilizing an interaction between the catalytic core domain (CCD) and carboxy-terminal domain (CTD) that undermines viral particle formation in late replication. Ongoing challenges with inhibitor potency, toxicity, and viral resistance motivate research to understand their mechanism. Here, we report a 2.93 Å X-ray crystal structure of the minimal ternary complex between CCD(,) CTD(,) and the ALLINI BI-224436. This structure reveals an asymmetric ternary complex with a prominent network of π-mediated interactions that suggest specific avenues for future ALLINI development and optimization. Public Library of Science 2023-03-03 /pmc/articles/PMC10016701/ /pubmed/36867659 http://dx.doi.org/10.1371/journal.ppat.1011097 Text en © 2023 Eilers et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Eilers, Grant
Gupta, Kushol
Allen, Audrey
Montermoso, Saira
Murali, Hemma
Sharp, Robert
Hwang, Young
Bushman, Frederic D.
Van Duyne, Gregory
Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization
title Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization
title_full Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization
title_fullStr Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization
title_full_unstemmed Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization
title_short Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization
title_sort structure of a hiv-1 in-allosteric inhibitor complex at 2.93 å resolution: routes to inhibitor optimization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016701/
https://www.ncbi.nlm.nih.gov/pubmed/36867659
http://dx.doi.org/10.1371/journal.ppat.1011097
work_keys_str_mv AT eilersgrant structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT guptakushol structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT allenaudrey structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT montermososaira structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT muralihemma structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT sharprobert structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT hwangyoung structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT bushmanfredericd structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization
AT vanduynegregory structureofahiv1inallostericinhibitorcomplexat293aresolutionroutestoinhibitoroptimization